Pharmaceutical combination comprising TNO155 and nazartinib

The present invention relates to a pharmaceutical combination comprising TNO155 and nazartinib; pharmaceutical compositions comprising the same; and methods of using such combinations and compositions in the treatment or prevention of conditions in a SHP2 inhibitor combined with EGFR inhibition is b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MOODY, Susan E, HAO, Huaixiang, LIU, Chen
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to a pharmaceutical combination comprising TNO155 and nazartinib; pharmaceutical compositions comprising the same; and methods of using such combinations and compositions in the treatment or prevention of conditions in a SHP2 inhibitor combined with EGFR inhibition is beneficial in, for example, the treatment of cancers.